EP2560679A4 - Eczema treatment - Google Patents

Eczema treatment

Info

Publication number: EP2560679A4
Authority: EP; European Patent Office
Prior art keywords: eczema treatment; eczema; treatment
Prior art date: 2010-04-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP11771412.1A

Other languages

German (de)

French (fr)

Other versions

EP2560679A1 (en

Inventor

Rudi Ganter

Humera Ahmad

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Probiotec Ltd

Original Assignee

Probiotec Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-04-23

Filing date

2011-04-21

Publication date

2013-09-18

2010-04-23 Priority claimed from AU2010901718A external-priority patent/AU2010901718A0/en

2011-04-21 Application filed by Probiotec Ltd filed Critical Probiotec Ltd

2011-04-21 Priority to EP17162198.0A priority Critical patent/EP3210618A1/en

2013-02-27 Publication of EP2560679A1 publication Critical patent/EP2560679A1/en

2013-09-18 Publication of EP2560679A4 publication Critical patent/EP2560679A4/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39508—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from milk, i.e. lactoglobulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
- C07K2317/522—CH1 domain
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Microbiology (AREA)
Mycology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Virology (AREA)
Pulmonology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

EP11771412.1A 2010-04-23 2011-04-21 Eczema treatment Withdrawn EP2560679A4 (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
EP17162198.0A EP3210618A1 (en)	2010-04-23	2011-04-21	Composition comprising lactoferrin and immunoglobulin for the treatment of eczema

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AU2010901718A AU2010901718A0 (en)		2010-04-23	Eczema treatment
PCT/AU2011/000467 WO2011130800A1 (en)	2010-04-23	2011-04-21	Eczema treatment

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
EP17162198.0A Division EP3210618A1 (en)	2010-04-23	2011-04-21	Composition comprising lactoferrin and immunoglobulin for the treatment of eczema

Publications (2)

Publication Number	Publication Date
EP2560679A1 EP2560679A1 (en)	2013-02-27
EP2560679A4 true EP2560679A4 (en)	2013-09-18

Family

ID=44833566

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
EP17162198.0A Withdrawn EP3210618A1 (en)	2010-04-23	2011-04-21	Composition comprising lactoferrin and immunoglobulin for the treatment of eczema
EP11771412.1A Withdrawn EP2560679A4 (en)	2010-04-23	2011-04-21	Eczema treatment

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
EP17162198.0A Withdrawn EP3210618A1 (en)	2010-04-23	2011-04-21	Composition comprising lactoferrin and immunoglobulin for the treatment of eczema

Country Status (5)

Country	Link
US (2)	US20130039903A1 (en)
EP (2)	EP3210618A1 (en)
CN (2)	CN105412912A (en)
AU (1)	AU2011242415B2 (en)
WO (1)	WO2011130800A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2942850T3 (en)	2015-06-01	2023-06-07	Saisei Pharma Co Ltd	Enzyme-treated dairy product, production process, composition and product
EP3479699A1 (en) *	2017-11-03	2019-05-08	Agriculture and Food Development Authority (TEAGASC)	A composition and uses thereof
WO2021209652A1 (en)	2020-04-16	2021-10-21	Dermopartners,S.L.	New composition for use to treat and prevent infections by covid-19 and other coronaviruses
FR3117736B1 (en) *	2020-12-22	2024-04-05	Savencia	New process for preparing a cationic whey protein isolate and the product thus obtained

Citations (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4436658A (en) *	1981-05-15	1984-03-13	Societe Nationale Elf Aquitaine	Process of extraction of lactoferrine and immunoglobulins of milk
JPH07233086A (en) *	1994-02-24	1995-09-05	Morinaga Milk Ind Co Ltd	Animal skin disease treatment agent
JPH0813754B2 (en) *	1987-11-19	1996-02-14	有限会社野々川商事	Topical skin
US5531989A (en) *	1994-10-28	1996-07-02	Metagenics, Inc.	Immunoglobulin and fiber-containing composition for human gastrointestinal health
WO1996028186A1 (en) *	1995-03-14	1996-09-19	Mendes S.R.L.	Use of g class immunoglobulins for the topical treatment of atopic dermatitis
WO1997005884A1 (en) *	1995-08-07	1997-02-20	New England Medical Center Hospitals, Inc.	Infant formula and infant formula additives
WO2007022537A2 (en) *	2005-08-19	2007-02-22	Agennix Incorporated	Use of lactoferrin as a chemokine and a chemotactic modulator
WO2007057748A2 (en) *	2005-11-18	2007-05-24	Umberto Cornelli	Use of colostrum for the prophylaxis of influenza syndromes
WO2008095276A1 (en) *	2007-02-06	2008-08-14	Cymcorp International, Inc.	Novel non-toxic composition and method of using such for treating a degenerative or an immune system-related disease
WO2010028652A1 (en) *	2008-09-12	2010-03-18	Nanoko A/S	Colostrum composition
JP2010229101A (en) *	2009-03-27	2010-10-14	Nrl Pharma Inc	Composition for skin
EP2275104A2 (en) *	2009-06-17	2011-01-19	Valetudo S.r.l.	Pharmaceutical and cosmetic composition including lactoferrin, ciclopirox and etidronic acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH10212246A (en) *	1997-01-30	1998-08-11	Nippon Zoki Pharmaceut Co Ltd	Preparation for oral administration
JP2001519815A (en) *	1997-04-10	2001-10-23	エイジェニックス・インコーポレイテッド	Use of lactoferrin in the treatment of allergen-induced disorders
JP2005068060A (en) *	2003-08-22	2005-03-17	Nrl Pharma Inc	Pharmaceutical composition containing lactoferrin and method for producing processed food containing lactoferrin
EP1993592A4 (en) *	2006-02-21	2011-11-16	Ventria Bioscience	Compositions containing lactoferrin, and methods of using same to promote growth of skin cells
DK2392343T3 (en) *	2006-07-03	2019-01-28	Perraudin Jean Paul	Antimicrobial compositions comprising hypohalite and / or hypothiocyanite and applications thereof
EP2164515A4 (en) *	2007-06-11	2011-04-27	Advitech Inc	Method for the treatment of atopic eczema

2011
- 2011-04-21 CN CN201510795379.4A patent/CN105412912A/en active Pending
- 2011-04-21 WO PCT/AU2011/000467 patent/WO2011130800A1/en not_active Ceased
- 2011-04-21 AU AU2011242415A patent/AU2011242415B2/en not_active Ceased
- 2011-04-21 US US13/641,191 patent/US20130039903A1/en not_active Abandoned
- 2011-04-21 CN CN2011800284578A patent/CN103002907A/en active Pending
- 2011-04-21 EP EP17162198.0A patent/EP3210618A1/en not_active Withdrawn
- 2011-04-21 EP EP11771412.1A patent/EP2560679A4/en not_active Withdrawn
2016
- 2016-08-08 US US15/230,814 patent/US20170028033A1/en not_active Abandoned

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4436658A (en) *	1981-05-15	1984-03-13	Societe Nationale Elf Aquitaine	Process of extraction of lactoferrine and immunoglobulins of milk
JPH0813754B2 (en) *	1987-11-19	1996-02-14	有限会社野々川商事	Topical skin
JPH07233086A (en) *	1994-02-24	1995-09-05	Morinaga Milk Ind Co Ltd	Animal skin disease treatment agent
US5531989A (en) *	1994-10-28	1996-07-02	Metagenics, Inc.	Immunoglobulin and fiber-containing composition for human gastrointestinal health
WO1996028186A1 (en) *	1995-03-14	1996-09-19	Mendes S.R.L.	Use of g class immunoglobulins for the topical treatment of atopic dermatitis
WO1997005884A1 (en) *	1995-08-07	1997-02-20	New England Medical Center Hospitals, Inc.	Infant formula and infant formula additives
WO2007022537A2 (en) *	2005-08-19	2007-02-22	Agennix Incorporated	Use of lactoferrin as a chemokine and a chemotactic modulator
WO2007057748A2 (en) *	2005-11-18	2007-05-24	Umberto Cornelli	Use of colostrum for the prophylaxis of influenza syndromes
WO2008095276A1 (en) *	2007-02-06	2008-08-14	Cymcorp International, Inc.	Novel non-toxic composition and method of using such for treating a degenerative or an immune system-related disease
WO2010028652A1 (en) *	2008-09-12	2010-03-18	Nanoko A/S	Colostrum composition
JP2010229101A (en) *	2009-03-27	2010-10-14	Nrl Pharma Inc	Composition for skin
EP2275104A2 (en) *	2009-06-17	2011-01-19	Valetudo S.r.l.	Pharmaceutical and cosmetic composition including lactoferrin, ciclopirox and etidronic acid

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ANDO K: "Pharmaceutical composition for preventing and treating e.g. arthritis,contains e.g. fatty acids, lactoferrin, vitamins, calcium salt,glucosamine sulfate, chondroitin sulfate, colostrum powder, and extract of cayenne pepper and ginger", WPI / THOMSON,, vol. 2005, no. 24, 17 March 2005 (2005-03-17), XP002642319 *
ANONYMOUS: "Did You Know Breastmilk Can Cure These Ailments?", 16 September 2007 (2007-09-16), pages 1 - 4, XP055145008, Retrieved from the Internet <URL:http://web.archive.org/web/20090520193821/http://www.associatedcontent.com/article/373334/did_you_know_breastmilk_can_cure_these.html?cat=5> [retrieved on 20141008] *
DATABASE WPI Week 199544, Derwent World Patents Index; AN 1995-340208, XP002709608 *
DATABASE WPI Week 201070, Derwent World Patents Index; AN 2010-N03298, XP002709607 *
See also references of WO2011130800A1 *
SUSAN STEPHENS ET AL: "Differences in inhibition of the growth of commensal and enteropathogenic strains of Escherichia coli by lactotransferrin and secretory immunoglobulin A isolated from human milk", IMMUNOLOGY, vol. 41, no. 3, 1 January 1980 (1980-01-01), pages 597 - 603, XP055074197 *
TOMITA M ET AL: "Bovine lactoferrin and lactoferricin derived from milk: production and applications", BIOCHEMISTRY AND CELL BIOLOGY. BIOCHIMIE ET BIOLOGIE CELLULAIRE, NRC RESEARCH PRESS, CA, vol. 80, no. 1, 1 January 2002 (2002-01-01), pages 109 - 112, XP008144405, ISSN: 0829-8211, [retrieved on 20020129], DOI: 10.1139/O01-230 *

Also Published As

Publication number	Publication date
AU2011242415B2 (en)	2017-02-16
CN103002907A (en)	2013-03-27
AU2011242415A1 (en)	2012-11-29
EP3210618A1 (en)	2017-08-30
WO2011130800A1 (en)	2011-10-27
EP2560679A1 (en)	2013-02-27
US20170028033A1 (en)	2017-02-02
US20130039903A1 (en)	2013-02-14
CN105412912A (en)	2016-03-23

Publication	Publication Date	Title
PL2652193T3 (en)	2021-01-25	Treatment
DK2786756T3 (en)	2020-04-27	Kombinationsterapi med en topoisomeraseinhibitor
EP2588419A4 (en)	2014-05-21	Wastewater treatment
EP2521569A4 (en)	2013-05-22	Combined treatment utilizing vb-201
IL222958A0 (en)	2013-02-03	Cancer treatment
IL220594A0 (en)	2012-08-30	Treatment method
ZA201209759B (en)	2014-03-26	Keloid treatment
IL223290A0 (en)	2013-02-03	Arthritis treatment
GB201013573D0 (en)	2010-09-29	Treatment
EP2560679A4 (en)	2013-09-18	Eczema treatment
GB201022066D0 (en)	2011-02-02	Reduced instructions set
ZA201308117B (en)	2014-12-23	Avian-based treatment
GB201014097D0 (en)	2010-10-06	Treatment
GB201102283D0 (en)	2011-03-23	Treatment
AU2010901718A0 (en)	2010-05-13	Eczema treatment
GB201021319D0 (en)	2011-01-26	Treatment
GB201007429D0 (en)	2010-06-16	Treatment regime
GB201007488D0 (en)	2010-06-16	Treatment regime
IL222594A0 (en)	2012-12-31	Combined treatment utilizing vb-201
GB201013530D0 (en)	2010-09-29	Finishing treatment
GB201009806D0 (en)	2010-07-21	Sewage treatment
GB201102271D0 (en)	2011-03-23	Treatment
GB201102266D0 (en)	2011-03-23	Treatment
GB201102284D0 (en)	2011-03-23	Treatment
GB201109119D0 (en)	2011-07-13	Treatment

Legal Events

Date	Code	Title	Description
2013-01-25	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2013-02-27	17P	Request for examination filed	Effective date: 20121122
2013-02-27	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2013-07-31	DAX	Request for extension of the european patent (deleted)
2013-09-11	RIC1	Information provided on ipc code assigned before grant	Ipc: A61P 17/00 20060101ALI20130807BHEP Ipc: A61P 37/08 20060101ALI20130807BHEP Ipc: A61K 38/40 20060101AFI20130807BHEP Ipc: A61K 39/395 20060101ALI20130807BHEP Ipc: A61K 38/17 20060101ALI20130807BHEP Ipc: A61K 35/20 20060101ALI20130807BHEP
2013-09-18	A4	Supplementary search report drawn up and despatched	Effective date: 20130816
2014-11-12	17Q	First examination report despatched	Effective date: 20141014
2017-03-31	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN
2017-05-03	18W	Application withdrawn	Effective date: 20170323